Korro Bio (KRRO) Research Hub

Korro Bio (KRRO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 12.02 USD (+0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.00, market cap 0.12B. This hub links to the full technical, earnings and options research available for KRRO.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close12.02 USD (+0.33%)
52-week range8.34 USD – 15.55 USD
Trend regimeRange
14-day RSI64.3 (Bullish)
Trailing P/E-1.00
Market cap0.12B
Dividend yield0.00%
Next earnings2026-08-11

Available research for KRRO

Earnings

KRRO earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -1.00. Updated 2026-07-23.

Options: Covered Call

Covered Call on KRRO: how it works, illustrative setup around the real 12.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on KRRO: how it works, illustrative setup around the real 12.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on KRRO: how it works, illustrative setup around the real 12.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

KRRO technical analysis: range, last 12.02 USD, RSI 64.3, 52w range 8.34 USD–15.55 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is KRRO in?

Korro Bio (KRRO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is KRRO in an uptrend or downtrend?

As of 2026-10-26, KRRO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is KRRO's trailing P/E ratio?

KRRO's trailing P/E is -1.00, with a market cap of 0.12B. See the earnings research page for full valuation detail.

When does KRRO next report earnings?

KRRO is next scheduled to report earnings on 2026-08-11.